Home > Products > 54024-22-5

54024-22-5
Desogestrel

Catalog#:1P003PQF

CAS:54024-22-5

MDL:MFCD00869346

Molecular Formula:C22H30O

Molecular Weight:310.4730

UN Number:

Haz Class:

Packing Group:

Synonyms: 13 Ethyl 11 methylene 18,19 dinor 17 alpha pregn 4 en 20 yn 17 ol; 13-Ethyl-11-methylene-18,19-dinor-17 alpha-pregn-4-en-20-yn-17-ol; 54024-22-5; H044; D017135; 17-Ethynyl-18-methyl-11-methyleneestr-4-en-17beta-ol; 13 Ethyl 11 methylene 18,19 dinor 17 alpha pregn 4 en 20 yn 17 ol; alpha-pregn-4-en-20-yn-17-ol, 13-Ethyl-11-methylene-18,19-dinor-17; (+)-13beta-Ethyl-17alpha-ethynyl-11-methylenegon-4-en-17beta-ol; 17-alpha-ethynyl-18-methyl-11-methylene-delta-4-estren-17-beta-ol; (+)-13.beta.-etil-etinil-17.alfa.-11-metilenegon-4-en-ol-17.beta.; 13-Ethyl-11-methylene-18 19-dinor-17alpha-4-pregnen-20-yn-17-ol; 18,19-Dinorpregn-4-en-20-in-17-ol, 13-etil-11-metileno-, (17alfa)-; Cerazette; 18,19-Dinorpregn-4-en-20-yn-17-ol, 13-ethyl-11-methylene-, (17.alpha.)-; Desogestrel, 99%, a third-generation 19-nortestosterone derivative progestogen - 100mg 100mg; Desogestrelum; desogen; Org-2969; Desogestrelum [INN-Latin]; ORG 2969; 13-Ethyl-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-17-ol; UNII-81K9V7M3A3; HSDB 3593; alpha-pregn-4-en-20-yn-17-ol, 13-Ethyl-11-methylene-18,19-dinor-17; EINECS 258-929-4; CHEBI:4453; C22H30O; 81K9V7M3A3; (8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-11-methylidene-1,2,3,6,7,8,9,10,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-ol; NCGC00167449-01; 18,19-Dinorpregn-4-en-20-yn-17-ol, 13-ethyl-11-methylene-, (17alpha)-; 13-ethyl-11-methylene-18,19-dinorpregn-4-en-20-yn-17alpha-ol; Desogestrel [USAN:BAN:INN]; SR-01000883959; Cerazette; Desogestrel (USAN/INN); Desogestrel [USAN:INN:BAN]; MFCD00869346; 13-Ethyl-11-methylene-18,19-dinor-17 alpha-pregn-4-en-20-yn-17-ol; DSSTox_CID_2898; CHEMBL1533; DSSTox_RID_76779; DSSTox_GSID_22898; SCHEMBL41341; AC1L24T4; Desogestrel; AC1Q282A; GTPL7065; DTXSID6022898; CTK8F9084; RPLCPCMSCLEKRS-BPIQYHPVSA-N; 17alpha-ethynyl-11-methylidene-18a-homo-estr-4-en-17beta-ol; BCP18794; ZINC4097416; Tox21_112453; AC-308; Marvelon; BDBM50423510; LMST02030104; s4638; (17alpha)-13-Ethyl-11-methylene-18,19-dinorpregn-4-en-20-yn-17-ol; AKOS015963198; ACN-037024; CS-3686; DB00304; VA10694; AN-15971; Org 2969; AS-13022; BC216009; CC-26355; HY-12516; LS-62079; SC-16229; CAS-54024-22-5; B4976; D4163; FT-0640213; Org-2969; C07629; D02367; Desogestrel, VETRANAL(TM), analytical standard; 024D225; C-19240; J-520217; SR-01000883959-1; SR-01000883959-2; 17alpha-ethynyl-13beta-ethyl-11-methylene-4-gonen-17-ol; Desogestrel, British Pharmacopoeia (BP) Reference Standard; Org2969; Desogestrel, European Pharmacopoeia (EP) Reference Standard; Desogestrel, United States Pharmacopeia (USP) Reference Standard; Desogestrel, Pharmaceutical Secondary Standard; Certified Reference Material; 18,19-Dinorpregn-4-en-20-yn-17-ol, 13-ethyl-11-methylene-, (17-alpha)-; Desogestrel for system suitability, European Pharmacopoeia (EP) Reference Standard; (8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-11-methylene-1,2,3,6,7,8,9,10,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-ol; Cyclessa; Marvelon; Mircette; Kariva; DESOGESTREL; Cyclosa; ortho-Cept; Mixture Name; D06CGB; Org2969; Organon Brand of Desogestrel; CID40973; C22-H30-O; CS-O-01372; DESOGESTREL AND ETHINYL ESTRADIOL;

Keywords: 54024-22-5,MFCD00869346,1P003PQF,Desogestrel,C22H30O

Inquire
Catalog# Purity Size Price Dis. Price Availability Quantity
1P003PQF >98.0%(HPLC) 100mg $191.00 $144.00 In Stock USA ADD TO CART BUY NOW

  • In chemical synthesis, $name$ (13-ethyl-17-ethynyl-11-methylene-1,2,3,6,7,8,9,10,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-ol;(17α)-13-Ethyl-11-methylene-18,19-dinorpregn-4-en-20-yn-17-o) serves as a valuable starting material for the production of various pharmaceutical compounds. Its unique structure containing multiple functional groups makes it a versatile building block for the synthesis of biologically active molecules. By selectively modifying different parts of the molecule, chemists can design and create novel drug candidates with specific pharmacological properties. This compound's structural complexity allows for strategic transformations that can lead to the development of new drugs for medical applications.

Copyright C 2019 1PlusChem LLC. All Right Reserved